| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 971,000 | 2,554,000 | 1,647,000 | 1,739,000 | | Cost of Revenue | 1,363,000 | 359,000 | 364,000 | 368,000 | | | Gross Profit | (392,000) | 2,195,000 | 1,283,000 | 1,371,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (415,000) | 407,000 | 346,000 | 353,000 | | Non Recurring | 1,000 | 1,000 |
-
|
-
| | Others | (847,000) | 965,000 | 56,000 | 52,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 869,000 | 822,000 | 881,000 | 966,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19,000 | 505,000 | 35,000 | 18,000 | | Earnings Before Interest And Taxes | 888,000 | 1,327,000 | 917,000 | 983,000 | | Interest Expense | 25,000 | 30,000 | 30,000 | 30,000 | | Income Before Tax | 863,000 | 1,297,000 | 887,000 | 953,000 | | Income Tax Expense | 349,000 | 568,000 | 352,000 | 379,000 | | Minority Interest |
-
|
-
| 1,000 |
-
| | | | Net Income From Continuing Ops | 514,000 | 729,000 | 536,000 | 574,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 514,000 | 729,000 | 536,000 | 574,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $514,000 | $729,000 | $536,000 | $574,000 |
|
0.02% Nasdaq 0.00%
Income Statement
